<DOC>
	<DOCNO>NCT00255554</DOCNO>
	<brief_summary>Subjects receive six month DBT , consist one 90-minute group one 60-minute individual session per week well telephone availability individual therapist . Half subject concurrently receive escitalopram half receive placebo , randomize double-blind design .</brief_summary>
	<brief_title>DBT Escitalopram Borderline Personality Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Is male female 18 60 meet criteria Borderline Personality Disorder psychotropic medication least 2 week ( 6 week fluoxetine ) . Meets criteria Schizophrenia , Bipolar Disorder , Mental Retardation , current recent Substance Dependence current Major Depressive Episode . Subjects also currently individual psychotherapy . ( Case management work therapy program allow . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Borderline Personality Disorder</keyword>
	<keyword>BPD</keyword>
	<keyword>Dialectical Behavior Therapy</keyword>
	<keyword>DBT</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Lexapro</keyword>
</DOC>